AbbVie to buy ImmunoGen to boost cancer drug portfolio AbbVie said today it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market for cancer treatments. Business • 30 Nov 23
AbbVie to buy ImmunoGen to boost cancer drug portfolio AbbVie said today it will buy drugmaker ImmunoGen for $10.1 billion, boosting its presence in the market for cancer treatments. Business • 30 Nov 23
